Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
Hold with a pointer, or hold Space or Enter.
News
AbbVie’s menstrual migraine treatment meets late-stage study goal
4+ day, 6+ hour ago (161+ words) Sept 10 (Reuters) – AbbVie said on Thursday its migraine treatment had in a late-stage study reduced the migraine days associated with the menstrual period. The drug, chemically known as atogepant, is approved under brand name Qulipta in the U.S. as…...